NO ONE IS ABOVE THE LAW -EXCEPT THOSE WHO ARE IN CHARGE OF ENFORCING OUR LAWS

Read this and weep – AGs and National Opioid Agreement – nicely put CPs OUT IN THE COLD  It would appear that many different parts of our federal and state bureaucracy are focusing on cutting the availability of FDA-approved controlled opioids. I guess that the DOJ/DEA was not shutting down practitioners’ offices fast enough.  More and more people were being poisoned/dying by illegal Fentanyl, but the media keeps referring to all the deaths are from JUST FENTANYL. Never mind that all the lethal illegal fentanyl was coming from CHINA & MEX CARTELS.  So the NATIONAL OPIOID AGREEMENT was to get the wholesalers to RATION OPIOIDS to community pharmacies.

STILL NOT FAST ENOUGH. Now, someone has talked the FDA into attempting to remove all extended-release opioid medications from being available.  Opioid medications have been commercially available in the United States for well over a century. If one reads the “fine print” on the website to place your comment. Comment Period Ends: May 4, 2025 at 11:59 PM EDT

We have an estimated 30% of the population dealing with chronic pain. Just imagine how many chronic painers can hold down a job because of long-acting opioids, and if they lose their long-acting opioids, many may end up on Medicare disability. We all know just how generous Medicare disability payments are! Just imagine how many chronic painers will not be able to get a good night’s restorative sleep.

MY MONEY IS ON THE FACT THAT AG PAM BONDI WILL DO NOTHING ABOUT DENYING CHRONIC PAINERS ACCESS TO FDA-APPROVED PAIN MEDICATION

 

Below is a federal law signed into law in 1935 – 35 years BEFORE the CONTROLLED SUBSTANCES ACT was signed into law. I am not an attorney, but  42 USC 1395 would seem to indicate that anyone in the federal government is prohibited from interfering with the practice of medicine.  Regardless of this nearly century-old law, the DOJ/DEA is repeatedly doing just that – over and over and over again.

Is AG Pam Bondi going to arrest some of the people within her DOJ agency for violating many federal laws? She is shown in the above video, where she is talking about arresting judges who are under her DOJ agency and have broken a few federal laws.

 Here is one of Pam Bondi’s re-election TV ads – running for FL AG – from about 10 yrs ago.

Dr Ruan and Dr Meredith Taking out the best of us to terrify the rest

Why was the SCOTUS (9-0) ruling on Ruan/Kahn a non-starter?

The June 2022 SCOTUS ruling that the DEA must NOT USE OBJECTIVE CRITERIA in judging prescribers in what they prescribe to pts dealing with SUBJECTIVE CRITERIA.

42 USC 1395: Prohibition against any Federal interference

https://uscode.house.gov/view.xhtml?req=(title:42%20section:1395%20edition:prelim)

From Title 42-THE PUBLIC HEALTH AND WELFARE CHAPTER 7-SOCIAL SECURITY SUBCHAPTER XVIII-HEALTH INSURANCE FOR AGED AND DISABLED

§1395. Prohibition against any Federal interference

Nothing in this sub chapter shall be construed to authorize any Federal officer or employee to exercise any supervision or control over the practice of medicine or the manner in which medical services are provided, or over the selection, tenure, or compensation of any officer or employee of any institution, agency, or person providing health services; or to exercise any supervision or control over the administration or operation of any such institution, agency, or person.

(Aug. 14, 1935, ch. 531, title XVIII, §1801, as added Pub. L. 89–97, title I, §102(a), July 30, 1965, 79 Stat. 291 .)

Statutory Notes and Related Subsidiaries

Short Title

For short title of title I of Pub. L. 89–97, which enacted this subchapter as the “Health Insurance for the Aged Act”, see section 100 of Pub. L. 89–97, set out as a Short Title of 1965 Amendment note under section 1305 of this title.

Protecting and Improving Guaranteed Medicare Benefits

Pub. L. 111–148, title III, §3601, Mar. 23, 2010, 124 Stat. 538 , provided that:

“(a) Protecting Guaranteed Medicare Benefits.-Nothing in the provisions of, or amendments made by, this Act [see Short Title note set out under section 18001 of this title] shall result in a reduction of guaranteed benefits under title XVIII of the Social Security Act [42 U.S.C. 1395 et seq.].

“(b) Ensuring That Medicare Savings Benefit the Medicare Program and Medicare Beneficiaries.-Savings generated for the Medicare program under title XVIII of the Social Security Act under the provisions of, and amendments made by, this Act shall extend the solvency of the Medicare trust funds, reduce Medicare premiums and other cost-sharing for beneficiaries, and improve or expand guaranteed Medicare benefits and protect access to Medicare providers.”


The FDA is about to make decisions that could permanently damage pain care in the United States … again.
On May 5th, a joint FDA advisory meeting will review two key studies (PMR 3033-1 & 3033-2) supposedly assessing the risks of extended-release/long-acting (ER/LA) opioid medications.
One of the many problems?
Neither of the studies has been made fully available for public review.
Stakeholders – patients, providers, researchers – are being asked to comment blindly on data that could determine access to critical medications for millions of Americans.
This is a textbook example of a process that violates transparency, scientific integrity, public trust, and possibly even federal law.
Even more concerning:
•The studies measure only risks (like misuse or overdose), but completely ignore benefits like improved quality of life, stability, and functionality for legitimate patients.
•Advocates tied to the anti-opioid lobby are pushing for redefinitions of opioid use disorder that could pathologize stable, compliant patients simply for needing medication.
•The Supreme Court’s recent overturning of Chevron Deference (Loper Bright v. Raimondo) means that regulatory decisions based on hidden, vague, or one-sided data are now more vulnerable to legal challenge. Agencies must get it right – or face judicial scrutiny.
I submitted my official comment when they briefly opened the docket back up.
We need as many voices as possible telling the FDA:
•No decisions should be made based on unpublished, incomplete, or opaque data
•Patient outcomes, functionality, and real-world harm must be included in any benefit / risk assessment
•Regulatory policy must not be driven by citation cartels or manufactured narratives
I’ve posted a couple of simple and brief templates you can use if you want to submit a comment quickly and easily. (Click here to go to my highlight section on X: https://x.com/impact2heal?s=21)
The deadline to be heard before the May 5th meeting is April 28th at midnight eastern time (8pm pacific time), so time is short. Even worse, the server is down currently until Monday so you’ll have to watch for the brief time between them opening back up and this docket closing.
We cannot afford silence.
Please watch for my next post and join us in defending ethical, transparent healthcare policy.
(Here is the link to read this docket yourself and to comment: https://www.regulations.gov/docket/FDA-2024-N-5331)

Leave a Reply

Discover more from PHARMACIST STEVE

Subscribe now to keep reading and get access to the full archive.

Continue reading